EFFECTIVENESS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: A COMBINED ANALYSIS OF REAL-WORLD EVIDENCE

被引：0
|
作者：
Cummings, Fraser
Buisson, Anthony
Smith, Philip J.
Rahmany, Sohail
Subramanian, Sreedhar
Kwon, Buki
Park, Soyeon
Lee, Young Nam
Fumery, Mathurin
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1854
引用
收藏
页码：S1144 / S1144
页数：1
相关论文
共 50 条
  • [1] Effectiveness of switching from intravenous to subcutaneous infliximab in Inflammatory Bowel Disease patients: A combined analysis of real-world evidence
    Cummings, F.
    Buisson, A.
    Smith, P. J.
    Rahmany, S.
    Subramanian, S.
    Kwon, B.
    Park, S.
    Lee, Y. N.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1332 - I1333
  • [2] Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
    Bergqvist, Viktoria
    Holmgren, Johanna
    Klintman, Daniel
    Marsal, Jan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1389 - 1401
  • [3] Effectiveness of Switching to Subcutaneous Infliximab in Pediatric Inflammatory Bowel Disease Patients on Intravenous Maintenance Therapy
    Gianolio, Laura
    Armstrong, Katherine
    Swann, Ewan
    Shepherd, Rhona
    Henderson, Paul
    Wilson, David C. C.
    Russell, Richard K. K.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (02): : 235 - 239
  • [4] CLINICAL EFFICACY AND DURABILITY OF SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER SWITCHING FROM INTRAVENOUS INFLIXIMAB: A REAL-WORLD MULTICENTER PROSPECTIVE COHORT STUDY IN KOREA
    Kim, Kyuwon
    Hong, Sung Noh
    Kang, Sang-Bum
    Lee, Kang-Moon
    Koo, Ja Seol
    Jung, Yunho
    Lee, Beom Jae
    Yoon, Hyuk
    Kim, Hyung Wook
    Lim, Yun Jeong
    Lee, Hyun Seok
    Lee, Yoo Jin
    Lee, Jun
    Lee, Chang Kyun
    Moon, Jung Min
    Shin, Seung Yong
    Seo, Jeongkuk
    Choi, Chang Hwan
    GASTROENTEROLOGY, 2024, 166 (05) : S1136 - S1136
  • [5] Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
    Buisson, Anthony
    Nachury, Maria
    Reymond, Maud
    Yzet, Clara
    Wils, Pauline
    Payen, Laure
    Laugie, Marie
    Manlay, Luc
    Mathieu, Nicolas
    Pereira, Bruno
    Fumery, Mathurin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2338 - 2346
  • [6] Transition from intravenous to subcutaneous infliximab: effectiveness in a cohort of patients with inflammatory bowel disease
    Todeschini, A.
    Geccherle, A.
    Signoretto, P.
    Colaci, N.
    Barugola, G.
    Variola, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1631 - I1631
  • [7] Safety and efficacy of transitioning inflammatory bowel disease patients from intravenous to subcutaneous infliximab: a single-center real-world experience
    Jeffrey, Angus W.
    Abu-Rgeef, Reeham
    Picardo, Sherman
    Menon, Shankar
    So, Kenji
    Venugopal, Kannan
    ANNALS OF GASTROENTEROLOGY, 2023, : 549 - 554
  • [8] Real-world subcutaneous infliximab for inflammatory bowel disease: A systematic review and meta-analysis
    Chetwood, J.
    Tran, Y.
    Subramanian, S.
    Smith, P.
    Iborra Colomino, M.
    Buisson, A.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 160 - 161
  • [9] Effectiveness of switching to subcutaneous infliximab in inflammatory bowel disease patients with inadequate biochemical response during intravenous administration
    Lee, Bokyeong
    Kim, Minjee
    Kim, Eun Ran
    Hong, Sung Noh
    Chang, Dong Kyung
    Kim, Young-Ho
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] Effectiveness of Switching to Subcutaneous Infliximab in Inflammatory Bowel Disease Patients with Inadequate Biochemical Response during Intravenous Administration
    Kim, M.
    Lee, B.
    Kim, E. R.
    Hong, S. N.
    Chang, D. K.
    Kim, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1443 - i1444
12345